Astellas, Amgen Pay $124M To Settle Drug Co-Pay Kickback Allegations By Government

(April 26, 2019, 11:34 AM EDT) -- BOSTON — Astellas Pharma US Inc. has agreed to pay $100 million and Amgen Inc. to pay $24.75 million to the United States to settle allegations that the companies violated the False Claims Act, 31 U.S. Code § 3729, by using charitable foundations to pay drug co-pays for patients while the remaining costs were paid by Medicare, according to an April 25 press release by the U.S. Justice Department....